Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools


You are here: Home
16 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Charles Perou Receives 2013 Battle Cancer Research Award
by William Shawn Davis published May 24, 2013 last modified May 24, 2013 04:04 PM — filed under:
Charles Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology, has been honored with the 2013 Hyman L. Battle Distinguished Cancer Research Award in recognition of his accomplishments in cancer research. Dr. Perou is a member of UNC Lineberger Comprehensive Cancer Center.
Located in News
Lymphedema therapy provides relief for cancer patients
by Dianne Shaw published Mar 25, 2013 last modified Apr 12, 2013 04:07 PM — filed under:
“It’s a lifesaver.” That’s how Frances Patterson, a breast cancer patient, describes the therapy she receives for lymphedema through the UNC Comprehensive Cancer Support Program.
Located in News
Human and canine lymphomas share molecular similarities, first large-scale comparison shows
by William Shawn Davis (wishda) published Jun 25, 2013 last modified Jun 26, 2013 09:07 AM — filed under:
Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it’s the most common lymphoma subtype while in dogs, it’s one of the most common cancers in veterinary oncology.
Located in News
Yeh and Johnson awarded Lustgarten Foundation grant for pancreatic cancer
by William Shawn Davis (wishda) published Jun 28, 2013 last modified Jun 28, 2013 12:37 PM — filed under:
Jen Jen Yeh, MD, and Gary Johnson, PhD, were awarded a $326,708.00 grant from the Lustgarten Foundation for a one-year pilot study to investigate the kinome landscape of pancreatic cancer.
Located in News
RNA Diagnostic Test from Paraffin Improves Lung Cancer Diagnosis Over Routine Microscopic Evaluation Alone
by William Shawn Davis (wishda) published Jul 16, 2013 last modified Jul 16, 2013 09:17 AM — filed under:
Knowing what type of lung cancer a patient has is critical to determine which drug will work best and which therapies are safest in the era of personalized medicine. Key to making that judgment is an adequate tumor specimen for the pathologist to determine the tumor’s histology, a molecular description of a tumor based on the appearance of cells under a microscope. But not all specimens are perfect, and are sometimes so complex that a definitive diagnosis presents a challenge.
Located in News
Factors Influencing Delay in Breast Cancer Treatment Differ For African-American and White Women
by William Shawn Davis (wishda) published Jul 09, 2013 last modified Jul 10, 2013 08:55 AM — filed under:
Different factors influence delay between diagnosis and first course of treatment for breast cancer for African-American and White women.
Located in News